info icon

Carcinoma in situ of other and unspecified parts of intestine

CD2_INSITU_INTESTINEOTH

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D01.4&
Hospital discharge: ICD-9 2307
Cause of death: ICD-10 D01.4&
Cause of death: ICD-9 2307

2 out of 7 registries used, show all original rules.

5

diagram downward connector

Check minimum number of events None

5

diagram downward connector

Include endpoints None

5

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

5

diagram downward connector
CD2_INSITU_INTESTINEOTH

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D01
Name in latin Carcinoma in situ partium aliarum sive non specificatarum intestini

Similar endpoints

List of similar endpoints to Carcinoma in situ of other and unspecified parts of intestine based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 5 - -
Unadjusted prevalence (%) 0.00 - -
Mean age at first event (years) 55.77 - -

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_INSITU_INTESTINEOTH – Carcinoma in situ of other and unspecified parts of intestine
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Carcinoma in situ of other and unspecified parts of intestine

Endpoint not on priority list, no data to show.